SPARC announces Phase 3 trial results of SDN-037 to treat inflammation and pain of ocular surgery Read more
COVID-19 clinical trial disruption declines but trials continue to suffer from slow recruitment Read more
Bristol Myers Squibb presents data from True North trial of Zeposia (ozanimod) for ulcerative colitis Read more
Umifenovir addition gives no significant clinical benefit in COVID-19 treatment: Glenmark study Read more
Vir Biotech research highlights mechanism to enhance monoclonal antibodies for inducing protective response Read more